Evonik Industries (EVK) Given a €29.00 Price Target at Independent Research

Independent Research set a €29.00 ($33.72) price target on Evonik Industries (FRA:EVK) in a research note released on Wednesday, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.

A number of other research firms have also recently weighed in on EVK. Sanford C. Bernstein set a €32.00 ($37.21) price objective on shares of Evonik Industries and gave the company a buy rating in a research report on Tuesday, January 8th. JPMorgan Chase & Co. set a €24.50 ($28.49) price objective on shares of Evonik Industries and gave the company a neutral rating in a research report on Thursday, January 10th. UBS Group set a €22.00 ($25.58) price objective on shares of Evonik Industries and gave the company a sell rating in a research report on Monday, January 14th. Credit Suisse Group set a €28.00 ($32.56) price objective on shares of Evonik Industries and gave the company a buy rating in a research report on Thursday, January 17th. Finally, Baader Bank set a €34.00 ($39.53) price objective on shares of Evonik Industries and gave the company a buy rating in a research report on Friday, January 18th. Three research analysts have rated the stock with a sell rating, nine have assigned a hold rating and ten have issued a buy rating to the company’s stock. Evonik Industries presently has an average rating of Hold and an average price target of €30.93 ($35.96).

EVK traded down €0.40 ($0.47) during trading hours on Wednesday, hitting €25.95 ($30.17). The company’s stock had a trading volume of 834,956 shares. Evonik Industries has a 12 month low of €26.78 ($31.14) and a 12 month high of €32.97 ($38.34).

Evonik Industries Company Profile

Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.

Further Reading: Discover Your Risk Tolerance

Analyst Recommendations for Evonik Industries (FRA:EVK)

Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.